Evidence map›Paper›PMID 37762266›Full record

ArticleInternational journal of molecular sciences2023

Development of Stable Amino-Pyrimidine-Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity.

Matteo Mari, Matteo Boniburini, Marianna Tosato, Luca Rigamonti, Laura Cuoghi, Silvia Belluti, Carol Imbriano, Giulia Avino, Mattia Asti, Erika Ferrari

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matteo MariDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.
Matteo BoniburiniDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.ORCID 0000-0003-0326-3570
Marianna TosatoDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.ORCID 0000-0002-3726-6174
Luca RigamontiDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.ORCID 0000-0002-9875-9765
Laura CuoghiDepartment of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/d, 41125 Modena, Italy.
Silvia BellutiDepartment of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/d, 41125 Modena, Italy.ORCID 0000-0003-0846-9359
Carol ImbrianoDepartment of Life Sciences, University of Modena and Reggio Emilia, Via Campi 213/d, 41125 Modena, Italy.ORCID 0000-0003-2864-4820
Giulia AvinoDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.
Mattia AstiRadiopharmaceutical Chemistry Section, Nuclear Medicine Unit, Azienda USL-IRCCS Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy.ORCID 0000-0001-7564-7405
Erika FerrariDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.ORCID 0000-0001-7627-2502

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the clear need for better cancer treatment, naturally occurring molecules represent a powerful inspiration. Recently, curcumin has attracted attention for its pleiotropic anticancer activity in vitro, especially against colorectal and prostate cancer cells. Unfortunately, these encouraging results were disappointing in vivo due to curcumin's low stability and poor bioavailability. To overcome these issues, herein, the synthesis of eight new pyrimidine-curcumin derivatives is reported. The compounds were fully characterized (

Indexed as

CurcuminAntihypertensive AgentsAntimetabolitesBiological AvailabilityCell SurvivalHumansMaleAntihypertensive AgentsAntimetabolitesCurcumincancer cellscell proliferationcurcuminpyrimidine derivativessolution equilibria

Identifiers

PMID37762266
PMCPMC10531168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.